<VariationArchive VariationID="289082" VariationName="NM_000070.3(CAPN3):c.2279dup (p.Asn760fs)" VariationType="Duplication" Accession="VCV000289082" Version="15" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-07-29" DateCreated="2016-12-06" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="273319" VariationID="289082">
      <GeneList>
        <Gene Symbol="CAPN3" FullName="calpain 3" GeneID="825" HGNC_ID="HGNC:1480" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q15.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="42359501" stop="42412317" display_start="42359501" display_stop="42412317" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="42651697" stop="42704514" display_start="42651697" display_stop="42704514" Strand="+" />
          </Location>
          <OMIM>114240</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000070.3(CAPN3):c.2279dup (p.Asn760fs)</Name>
      <CanonicalSPDI>NC_000015.10:42410897:AA:AAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>15q15.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="42410897" stop="42410898" display_start="42410897" display_stop="42410898" variantLength="1" positionVCF="42410897" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="42703095" stop="42703096" display_start="42703095" display_stop="42703096" variantLength="1" positionVCF="42703095" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>N95fs</ProteinChange>
      <ProteinChange>N668fs</ProteinChange>
      <ProteinChange>N760fs</ProteinChange>
      <ProteinChange>N248fs</ProteinChange>
      <ProteinChange>N754fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.42410899dup" Assembly="GRCh38">
            <Expression>NC_000015.10:g.42410899dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.42703097dup" Assembly="GRCh37">
            <Expression>NC_000015.9:g.42703097dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008660.1" sequenceAccession="NG_008660" sequenceVersion="1" change="g.67797dup">
            <Expression>NG_008660.1:g.67797dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000070.3" sequenceAccession="NM_000070" sequenceVersion="3" change="c.2279dup" MANESelect="true">
            <Expression>NM_000070.3:c.2279dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000061.1" sequenceAccession="NP_000061" sequenceVersion="1" change="p.Asn760fs">
            <Expression>NP_000061.1:p.Asn760fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024344.2" sequenceAccession="NM_024344" sequenceVersion="2" change="c.2261dup">
            <Expression>NM_024344.2:c.2261dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_077320.1" sequenceAccession="NP_077320" sequenceVersion="1" change="p.Asn754fs">
            <Expression>NP_077320.1:p.Asn754fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_173087.2" sequenceAccession="NM_173087" sequenceVersion="2" change="c.2003dup">
            <Expression>NM_173087.2:c.2003dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_775110.1" sequenceAccession="NP_775110" sequenceVersion="1" change="p.Asn668fs">
            <Expression>NP_775110.1:p.Asn668fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_173088.2" sequenceAccession="NM_173088" sequenceVersion="2" change="c.743dup">
            <Expression>NM_173088.2:c.743dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_775111.1" sequenceAccession="NP_775111" sequenceVersion="1" change="p.Asn248fs">
            <Expression>NP_775111.1:p.Asn248fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_173089.2" sequenceAccession="NM_173089" sequenceVersion="2" change="c.284dup">
            <Expression>NM_173089.2:c.284dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_775112.1" sequenceAccession="NP_775112" sequenceVersion="1" change="p.Asn95fs">
            <Expression>NP_775112.1:p.Asn95fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_173090.2" sequenceAccession="NM_173090" sequenceVersion="2" change="c.284dup">
            <Expression>NM_173090.2:c.284dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_775113.1" sequenceAccession="NP_775113" sequenceVersion="1" change="p.Asn95fs">
            <Expression>NP_775113.1:p.Asn95fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_849" sequenceAccession="LRG_849">
            <Expression>LRG_849:g.67797dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_849t1" sequenceAccession="LRG_849t1">
            <Expression>LRG_849t1:c.2279dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_849p1" sequenceAccession="LRG_849p1" change="p.Asn760fs">
            <Expression>LRG_849p1:p.Asn760fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000070.2" sequenceAccession="NM_000070" sequenceVersion="2" change="c.2279dup">
            <Expression>NM_000070.2:c.2279dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000070.2" sequenceAccession="NM_000070" sequenceVersion="2" change="c.2279dupA">
            <Expression>NM_000070.2:c.2279dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA7511816" DB="ClinGen" />
        <XRef Type="rs" ID="775130589" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000070.3(CAPN3):c.2279dup (p.Asn760fs) AND Autosomal recessive limb-girdle muscular dystrophy type 2A" Accession="RCV000399324" Version="7">
        <ClassifiedConditionList TraitSetID="5780">
          <ClassifiedCondition DB="MedGen" ID="C1869123">Autosomal recessive limb-girdle muscular dystrophy type 2A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-07-11" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000070.3(CAPN3):c.2279dup (p.Asn760fs) AND not provided" Accession="RCV000790763" Version="10">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-05-25" SubmissionCount="3">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000070.3(CAPN3):c.2279dup (p.Asn760fs) AND CAPN3-related disorder" Accession="RCV004535421" Version="1">
        <ClassifiedConditionList TraitSetID="33552">
          <ClassifiedCondition DB="MedGen" ID="CN239245">CAPN3-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000070.3(CAPN3):c.2279dup (p.Asn760fs) AND Muscular dystrophy, limb-girdle, autosomal dominant 4" Accession="RCV004567835" Version="1">
        <ClassifiedConditionList TraitSetID="44661">
          <ClassifiedCondition DB="MedGen" ID="C4748295">Muscular dystrophy, limb-girdle, autosomal dominant 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-09" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2016-12-06" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10330340</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15689361</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18055493</ID>
        </Citation>
        <DescriptionHistory Dated="2018-08-12">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-08-12">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="33552" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36442" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CAPN3-Related Disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CAPN3-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">CAPN3-related disorder</ElementValue>
              </Name>
              <XRef ID="CN239245" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="44661" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="40660" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1I</ElementValue>
                <XRef Type="MIM" ID="618129" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy, limb-girdle, autosomal dominant 4</ElementValue>
                <XRef ID="MONDO:0029133" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LGMDD4</ElementValue>
                <XRef Type="MIM" ID="618129" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LGMD1I</ElementValue>
                <XRef Type="MIM" ID="618129" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301490</ID>
                <ID Source="BookShelf">NBK1313</ID>
              </Citation>
              <XRef ID="C4748295" DB="MedGen" />
              <XRef ID="MONDO:0029133" DB="MONDO" />
              <XRef Type="MIM" ID="618129" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5780" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3064" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2A</ElementValue>
                <XRef ID="MONDO:0009675" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, limb-girdle, type 2A, Amish</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Calpainopathy</ElementValue>
                <XRef ID="NBK1313" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, pelvofemoral</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leyden-Moebius muscular dystrophy</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LGMD2</ElementValue>
                <XRef Type="MIM" ID="253600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR1</ElementValue>
                <XRef Type="MIM" ID="253600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Calpainopathy is characterized by symmetric and progressive weakness of proximal limb-girdle muscles. The age at onset of muscle weakness ranges from two to 40 years. The phenotype shows intra- and interfamilial variability ranging from severe to mild. Three autosomal recessive calpainopathy phenotypes have been identified based on the distribution of muscle weakness and age at onset: Pelvifemoral limb-girdle muscular dystrophy (LGMD) (Leyden-Möbius LGMD) phenotype, the most frequently observed calpainopathy phenotype, in which muscle weakness is first evident in the pelvic girdle and later in the shoulder girdle, with onset that may occur as early as before age 12 years or as late as after age 30 years. Scapulohumeral LGMD (Erb LGMD) phenotype, usually a milder phenotype with infrequent early onset, in which muscle weakness is first evident in the shoulder girdle and later in the pelvic girdle. HyperCKemia, usually observed in children or young individuals, in which individuals are asymptomatic and have high serum creatine kinase (CK) concentrations. The autosomal dominant form of calpainopathy shows a variability of clinical phenotype, ranging from almost asymptomatic to wheelchair dependence after age 60 years in few cases with a generally milder phenotype than the recessive form. Clinical findings of calpainopathy include the tendency to walk on tiptoe, difficulty in running, scapular winging, waddling gait, and slight hyperlordosis. Other findings include symmetric weakness of proximal more than distal muscles in the limbs, trunk, and periscapular area; laxity of the abdominal muscles; Achilles tendon shortening; scoliosis; and joint contractures. Affected individuals typically do not have cardiac involvement or intellectual disability.</Attribute>
                <XRef ID="NBK1313" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000557704" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521018" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000560317" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530423" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332444" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511445" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1057" />
                <XRef ID="1057" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301490</ID>
                <ID Source="BookShelf">NBK1313</ID>
              </Citation>
              <XRef ID="267" DB="Orphanet" />
              <XRef ID="C1869123" DB="MedGen" />
              <XRef ID="MONDO:0009675" DB="MONDO" />
              <XRef Type="MIM" ID="253600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1545858" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="587418|OMIM:253600" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000795555" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-11-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18055493</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CAPN3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="CA" referenceAllele="C" start="42703095" stop="42703095" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000070.2:c.2279dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253600" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="656890" SubmissionDate="2016-11-03" DateLastUpdated="2019-07-31" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="50277_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000343367" DateUpdated="2019-07-31" DateCreated="2016-12-06" Type="SCV" Version="3" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-07-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.2279dupA CAPN3 pathogenic variant has been reported in individuals with LGMD2A1,2 and is of a type expected to cause disease. 1. Groen et al. Brain. 2007 Dec;130(Pt 12):3237-49. 2. www.lovd.nl/CAPN3 AKT 7-1-16</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions</Attribute>
          <Citation Type="general">
            <URL>http://www.egl-eurofins.com/emvclass/EGLClassificationDefinitions.php</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CAPN3" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="A" referenceAllele="-" start="42703097" stop="42703098" variantLength="2" />
            <GeneLocation>NM_000070.2:Ex22</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI076941" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://geneticslab.emory.edu/emvclass/emvclass.php?approved_symbol=CAPN3</URL>
        </Citation>
        <Comment>The c.2279dupA CAPN3 pathogenic variant has been reported in individuals with LGMD2A1,2 and is of a type expected to cause disease. 1. Groen et al. Brain. 2007 Dec;130(Pt 12):3237-49. 2. www.lovd.nl/CAPN3 AKT 7-1-16</Comment>
        <SubmissionNameList>
          <SubmissionName>EGL004</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5398115" SubmissionDate="2022-12-07" DateLastUpdated="2022-12-11" DateCreated="2022-12-11">
        <ClinVarSubmissionID localKey="GDXSV:251118" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002759049" DateUpdated="2022-12-11" DateCreated="2022-12-11" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Observed with a pathogenic variant (p.Arg490Trp) in a patient in the published literature with Limb-girdle muscular dystrophy, but it is unknown whether the variants occurred on the same allele (in cis) or on different alleles (in trans) (Groen et al., 2007); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 18055493)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CAPN3" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:663357</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000070.2:c.2279dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_149_20221207054205</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7692238" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="26149717|CAPN3-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004105875" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The CAPN3 c.2279dupA variant is predicted to result in a frameshift and premature protein termination (p.Asn760Lysfs*5). This variant was reported in the compound heterozygous state in an individual with limb-girdle muscular dystrophy 2A (Groen et al 2007. PubMed ID: 18055493). This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/15-42703095-C-CA). Frameshift variants in CAPN3 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CAPN3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000070.2:c.2279dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CAPN3-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3965717" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="763adcf57c8064fc44d5eb91dca95a473917262ad2fa9d436ecbb1a38daa48a6|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002018089" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000070.3:c.2279dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3107162" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="2888661|MedGen:C1869123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001581543" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18055493</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10330340</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15689361</ID>
          </Citation>
          <Comment>This premature translational stop signal has been observed in individual(s) with autosomal recessive limb girdle muscular dystrophy (PMID: 18055493). This variant is also known as c.2278insA. ClinVar contains an entry for this variant (Variation ID: 289082). For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asn760Lysfs*5) in the CAPN3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CAPN3 are known to be pathogenic (PMID: 10330340, 15689361).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CAPN3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.42703095_42703096insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1869123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9816964" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_000070.3:c.2279dup|OMIM:618129" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005060002" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000070.3:c.2279dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="618129" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="656890" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9816964" TraitType="Disease" MappingType="XRef" MappingValue="618129" MappingRef="OMIM">
        <MedGen CUI="C4748295" Name="Muscular dystrophy, limb-girdle, autosomal dominant 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3965717" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1545858" TraitType="Disease" MappingType="XRef" MappingValue="253600" MappingRef="OMIM">
        <MedGen CUI="C1869123" Name="Autosomal recessive limb-girdle muscular dystrophy type 2A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7692238" TraitType="Disease" MappingType="Name" MappingValue="CAPN3-related condition" MappingRef="Preferred">
        <MedGen CUI="CN239245" Name="CAPN3-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5398115" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3107162" TraitType="Disease" MappingType="XRef" MappingValue="C1869123" MappingRef="MedGen">
        <MedGen CUI="C1869123" Name="Autosomal recessive limb-girdle muscular dystrophy type 2A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

